| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococci (coagulase-negative + methicillin-resistant) |
1 |
2 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
207 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
1 |
2 |
? － ? |
Ceftobiprole (Zeftera) |
942 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
1 |
4 |
0.03 － 64 |
Moxifloxacin (BAY 12-8039, Avelox) |
268 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
>1 |
>16 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
307 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
>1 |
>64 |
0.25 － >64 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
178 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
1 |
64 |
0.25 － 64 |
Tetracycline (Sumycin, Achromycin V, Steclin) |
1464 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
2 |
0.25 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
109 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
2 |
0.5 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
207 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
2 |
0.5 － 4 |
Oritavancin (LY333328) |
207 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
2 |
1 － 2 |
Vancomycin (Vancocyn, Lyphocin) |
72 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
2 |
1 － 4 |
Linezolid (PNU-100766, U-100766, Zyvox) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
2 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
89 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
2 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
16 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
2 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
175 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
2 |
1 － 4 |
Vancomycin (Vancocyn, Lyphocin) |
175 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
4 |
≤0.063 － 64 |
Gatifloxacin (Tequin) |
109 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
>2 |
>4 |
≤0.5 － >4 |
Co-trimoxazole (Trimethoprim-sulfamethoxazole, TMP-SMX) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
4 |
1 － 4 |
Oritavancin (LY333328) |
72 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
4 |
1 － 8 |
Vancomycin (Vancocyn, Lyphocin) |
178 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
>2 |
>8 |
≤0.06 － >8 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
8 |
≤0.063 － 16 |
Teicoplanin (Targocid) |
109 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
8 |
≤0.12 － 16 |
Teicoplanin (Targocid) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
8 |
≤0.12 － >32 |
Teicoplanin (Targocid) |
162 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
2 |
8 |
0.12 － 64 |
Teicoplanin (Targocid) |
67 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
>4 |
>5 |
0.5 － >4 |
Oxacillin (Prostaphilin, Bactocil, Prostaphlin) |
73 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
4 |
8 |
≤0.06 － >16 |
Levofloxacin (Levaquin, Quixin) |
207 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
4 |
8 |
0.5 － >16 |
Teicoplanin (Targocid) |
207 |
| Staphylococci (coagulase-negative + methicillin-resistant) |
4 |
16 |
0.12 － >128 |
Levofloxacin (Levaquin, Quixin) |
268 |